LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Sehrawat, Archana, Gao, Lina, Wang, Yuliang, Bankhead, Armand, McWeeney, Shannon K., King, Carly J., Schwartzman, Jacob, Urrutia, Joshua, Bisson, William H., Coleman, Daniel J., Joshi, Sunil K., Kim, Dae-Hwan, Sampson, David A., Weinmann, Sheila, Kallakury, Bhaskar V. S., Berry, Deborah L., Haque, Reina, Van Den Eeden, Stephen K., Sharma, Sunil, Bearss, Jared, Beer, Tomasz M., Thomas, George V., Heiser, Laura M., Alumkal, Joshi J.
Published in Proceedings of the National Academy of Sciences - PNAS (01.05.2018)
Published in Proceedings of the National Academy of Sciences - PNAS (01.05.2018)
Get full text
Journal Article
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer
Coleman, Daniel J, Gao, Lina, King, Carly J, Schwartzman, Jacob, Urrutia, Joshua, Sehrawat, Archana, Tayou, Junior, Balter, Ariel, Burchard, Julja, Chiotti, Kami E, Derrick, Daniel S, Sun, Duanchen, Xia, Zheng, Heiser, Laura M, Alumkal, Joshi J
Published in Oncogene (01.07.2019)
Published in Oncogene (01.07.2019)
Get full text
Journal Article
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
Coleman, Daniel J., Sampson, David A., Sehrawat, Archana, Kumaraswamy, Anbarasu, Sun, Duanchen, Wang, Yuzhuo, Schwartzman, Jacob, Urrutia, Joshua, Lee, Ahn R., Coleman, Ilsa M., Nelson, Peter S., Dong, Xuesen, Morrissey, Colm, Corey, Eva, Xia, Zheng, Yates, Joel A., Alumkal, Joshi J.
Published in Neoplasia (New York, N.Y.) (01.06.2020)
Published in Neoplasia (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
Role of SMC1 in overcoming drug resistance in triple negative breast cancer
Yadav, Sushma, Sehrawat, Archana, Eroglu, Zeynep, Somlo, George, Hickey, Robert, Yadav, Sailee, Liu, Xueli, Awasthi, Yogesh C, Awasthi, Sanjay
Published in PloS one (22.05.2013)
Published in PloS one (22.05.2013)
Get full text
Journal Article
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function
Kumaraswamy, Anbarasu, Duan, Zhi, Flores, Diana, Zhang, Chao, Sehrawat, Archana, Hu, Ya-Mei, Swaim, Olivia A, Rodansky, Eva, Storck, William K, Kuleape, Joshua A, Bedi, Karan, Mannan, Rahul, Wang, Xiao-Ming, Udager, Aaron, Ravikumar, Visweswaran, Bankhead, 3rd, Armand, Coleman, Ilsa, Lee, John K, Morrissey, Colm, Nelson, Peter S, Chinnaiyan, Arul M, Rao, Arvind, Xia, Zheng, Yates, Joel A, Alumkal, Joshi J
Published in JCI insight (08.08.2023)
Published in JCI insight (08.08.2023)
Get full text
Journal Article
Androgen receptor activity in T cells limits checkpoint blockade efficacy
Guan, Xiangnan, Polesso, Fanny, Wang, Chaojie, Sehrawat, Archana, Hawkins, Reed M, Murray, Susan E, Thomas, George V, Caruso, Breanna, Thompson, Reid F, Wood, Mary A, Hipfinger, Christina, Hammond, Scott A, Graff, Julie N, Xia, Zheng, Moran, Amy E
Published in Nature (London) (23.06.2022)
Published in Nature (London) (23.06.2022)
Get full text
Journal Article
Androgen receptor targeted therapy sensitizes tumor bearing mice to effective immunotherapy
Polesso, Fanny, Hipfinger, Christina, Sehrawat, Archana, Moran, Amy
Published in The Journal of immunology (1950) (01.05.2020)
Published in The Journal of immunology (1950) (01.05.2020)
Get full text
Journal Article
Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer
Gao, Lina, Coleman, Daniel J., King, Carly J., Schwartzman, Jacob, Wang, Nicholas, Esch, Amanda, Urrutia, Joshua, Sehrawat, Archana, Heiser, Laura M., Alumkal, Joshi J.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
P300 regulates the human RLIP76 promoter activity and gene expression
Sehrawat, Archana, Yadav, Sushma, Awasthi, Yogesh C., Basu, Alakananda, Warden, Charles, Awasthi, Sanjay
Published in Biochemical pharmacology (15.04.2013)
Published in Biochemical pharmacology (15.04.2013)
Get full text
Journal Article
Abstract LB-240: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Sehrawat, Archana, Kim, Dae-Hwan, Gao, Lina, Wang, Yuliang, Bankhead, Armand, McWeeney, Shannon, King, Carly J., Schwartzman, Jacob, Tayou, Junior, Urrutia, Joshua, Bisson, William H., Coleman, Daniel J., Joshi, Sunil K., Sampson, David A., Weinmann, Sheila, Kallakury, Bhaskar VS, Berry, Deborah L., Haque, Reina, Eeden, Stephen K. Van Den, Sharma, Sunil, Bearss, Jared, Beer, Tomasz M., Thomas, George V., Heiser, Laura M., Alumkal, Joshi J.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer
Singhal, Sharad S., Sehrawat, Archana, Sahu, Mukesh, Singhal, Preeti, Vatsyayan, Rit, Rao Lelsani, Poorna Chandra, Yadav, Sushma, Awasthi, Sanjay
Published in International journal of cancer (15.03.2010)
Published in International journal of cancer (15.03.2010)
Get full text
Journal Article
Abstract 3330: Overcoming drug resistance in triple negative breast cancer by targeting SMC1 and PARP
Yadav, Sushma, Eroglu, Zeynep, Sehrawat, Archana, Somlo, George, Yuan, Yate-Ching, Awasthi, Yogesh C., Awasthi, Sanjay
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 2406: LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation
Sehrawat, Archana, Gao, Lina, Tayou, Junior, Bankhead, Armand, Heiser, Laura M., King, Carly J., Wang, Yuliang, Schwartzman, Jacob, Urrutia, Joshua, Coleman, Daniel J., Weinmann, Sheila, Kallakury, Bhaskar V., Berry, Deborah L., Haque, Reina, Eeden, Stephen K. Van Den, Beer, Tomasz M., Thomas, George V., McWeeney, Shannon, Alumkal, Joshi J.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76
Singhal, Sharad S., Yadav, Sushma, Singhal, Jyotsana, Sahu, Mukesh, Sehrawat, Archana, Awasthi, Sanjay
Published in FEBS letters (15.10.2008)
Published in FEBS letters (15.10.2008)
Get full text
Journal Article
Androgen content and BET bromodomain proteins influence enzalutamide agonism of mutant F876L androgen receptor
Coleman, Daniel J., Van Hook, Kathryn, King, Carly J., Schwartzman, Jacob, Lisac, Robert, Urrutia, Joshua, Sehrawat, Archana, Woodward, Josha, Wang, Nicholas J., Gulati, Roman, Thomas, George V., Beer, Tomasz M., Gleave, Martin E., Korkola, James E., Gao, Lina, Heiser, Laura M., Alumkal, Joshi J.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
Coleman, Daniel J, Van Hook, Kathryn, King, Carly J, Schwartzman, Jacob, Lisac, Robert, Urrutia, Joshua, Sehrawat, Archana, Woodward, Josha, Wang, Nicholas J, Gulati, Roman, Thomas, George V, Beer, Tomasz M, Gleave, Martin, Korkola, James E, Gao, Lina, Heiser, Laura M, Alumkal, Joshi J
Published in Oncotarget (28.06.2016)
Published in Oncotarget (28.06.2016)
Get full text
Journal Article
Abstract 1525: RLIP76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer
Singhal, Sharad S., Sehrawat, Archana, Sahu, Mukesh, Singhal, Preeti, Vatsyayan, Rit, Lelsani, Poorna C R, Yadav, Sushma, Awasthi, Sanjay
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article